IP Library › Granted Patent US 11,517,531
Granted Patent B2
US 11,517,531 · App. 15/956,468 · Granted Dec 6, 2022

Cerium oxide nanoparticle compositions and methods

Inventors: Sudipta Seal (Oviedo, FL); Swetha Barkam (Orlando, FL); Amitava Adhikary (Rochester, MI)
Assignee: University of Central Florida Research Foundation, Inc.
A61K9/14A61K9/51A61K33/244C01F17/235A61K9/5115A61K9/5192B82Y5/00B82Y30/00B82Y40/00C01P2002/01C01P2002/84C01P2002/85C01P2002/86C01P2004/62C01P2004/64
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,517,531
App. No.
15/956,468
Granted
Dec 6, 2022
Kind
B2
Abstract

Cerium oxide nanoparticles (CNPs) have been proven to exhibit antioxidant properties attributed to its surface oxidation states (Ce4+ to Ce3+ and vice versa) mediated at the oxygen vacancies on the surface of CNPs. Different anions in precursor cerium salts were used to prepare CNPs resulting in disclosed CNPs with varying physicochemical properties such as dispersion stability, hydrodynamic size, and the signature surface chemistry. The antioxidant catalytic activity and oxidation potentials of different CNPs have been significantly altered with the change of anions in the precursor salts. For one, CNPs prepared using precursor salts containing NO 3 − and Cl − ions exhibited increased antioxidant activity than previously thought possible. The change in oxidation potentials of CNPs with the change in concentration of the nitrate and chloride ions indicates the disclosed CNP's have different surface chemistry and antioxidant properties. These compositions and methods of their synthesis are disclosed.

Claims (5)

1. A composition comprising cerium nanoparticles (CNPs) in the presence of chloride ions, the CNPs formed from a reduction of a cerium precursor salt having a chloride anion, and wherein the CNPs have a predominant 4+ surface charge and exhibit SOD mimetic activity, and wherein the CNPs are of a size range of 1 nm to 20 nm and comprise a zeta-potential of more than 30 mV.

2. A composition of claim 1 , wherein the concentration of the chloride ions is at least 0.03 mM.

3. The composition of claim 1 , wherein the chloride ions are produced by the reduction of the cerium precursor salt having a chloride anion.

4. The composition of claim 1 , wherein the composition comprises additional chloride ions in addition to any chloride ions produced by the reduction of the cerium precursor salt.

5. The composition of claim 4 , wherein the additional chloride ions are provided by adding sodium chloride.

Assignments (2)
LICENSE Recorded Feb 11, 2026
From: UNIVERSITY OF CENTRAL FLORIDA
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 073756/0996 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2019
From: SEAL, SUDIPTA; BARKAM, SWETHA
To: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION,INC.
Reel/Frame 050089/0172 →
Continuity (2)
Provisional Application 62486612 · Apr 18, 2017
Related Publication 20180339913A1 · Nov 29, 2018
Cited By (1)
US 12,447,126